Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Change in Cash (2016 - 2025)

Firefly Neuroscience has reported Change in Cash over the past 15 years, most recently at -$1.6 million for Q4 2025.

  • Quarterly results put Change in Cash at -$1.6 million for Q4 2025, down 372.07% from a year ago — trailing twelve months through Dec 2025 was $937000.0 (up 381.38% YoY), and the annual figure for FY2025 was $937000.0, up 381.38%.
  • Change in Cash for Q4 2025 was -$1.6 million at Firefly Neuroscience, up from -$1.6 million in the prior quarter.
  • Over the last five years, Change in Cash for AIFF hit a ceiling of $7.7 million in Q1 2025 and a floor of -$3.6 million in Q2 2025.
  • Median Change in Cash over the past 5 years was -$196390.5 (2023), compared with a mean of $78096.0.
  • Biggest five-year swings in Change in Cash: plummeted 805.85% in 2021 and later skyrocketed 1631.68% in 2025.
  • Firefly Neuroscience's Change in Cash stood at $1.2 million in 2021, then crashed by 163.31% to -$790570.0 in 2022, then soared by 258.11% to $1.2 million in 2023, then plummeted by 53.6% to $580000.0 in 2024, then tumbled by 372.07% to -$1.6 million in 2025.
  • The last three reported values for Change in Cash were -$1.6 million (Q4 2025), -$1.6 million (Q3 2025), and -$3.6 million (Q2 2025) per Business Quant data.